{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-165466","form_type":"8-K","ticker":"ABSI","cik":"0001672688","company_name":"Absci Corp","filed_at":"2025-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.605130+00:00","generated_at":"2026-05-18T01:11:04.354108+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Absci prices $50M public offering of 16.67M shares at $3.00 per share","bullets":["Offering of 16,670,000 shares at $3.00 per share; gross proceeds ~$50M.","Net proceeds estimated at ~$46.7M (or ~$53.7M if underwriters' option exercised in full).","Proceeds to fund internal programs, Integrated Drug Creation platform, and general corporate purposes.","Underwriters: Morgan Stanley, J.P. Morgan, Jefferies, TD Securities; expected close July 28, 2025.","Offer made under effective shelf registration statement on Form S-3 (File No. 333-267043)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-165466","json":"https://secwatch.observer/filing/0001193125-25-165466.json","markdown":"https://secwatch.observer/filing/0001193125-25-165466.md","text":"https://secwatch.observer/filing/0001193125-25-165466.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1672688/000119312525165466/0001193125-25-165466-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1672688/000119312525165466/d65613d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T01:11:04.354108+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}